These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2035982)

  • 41. [Monogenic severe insulin resistance syndromes].
    Vincent-Desplanques D; Faivre-Defrance F; Wémeau JL; Vantyghem MC
    Rev Med Interne; 2005 Nov; 26(11):866-73. PubMed ID: 15908053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generalized acanthosis nigricans related to type B insulin resistance syndrome: a case report.
    Jeong KH; Oh SJ; Chon S; Lee MH
    Cutis; 2010 Dec; 86(6):299-302. PubMed ID: 21284281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies against the insulin receptor in paraneoplastic acanthosis nigricans.
    Matsuoka LY; Goldman J; Wortsman J; Kleinsmith D; Kupchella CE
    Am J Med; 1987 Jun; 82(6):1253-6. PubMed ID: 3605142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic basis of endocrine disease. 1. Molecular genetics of insulin resistant diabetes mellitus.
    Taylor SI; Cama A; Accili D; Barbetti F; Imano E; Kadowaki H; Kadowaki T
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1158-63. PubMed ID: 1955495
    [No Abstract]   [Full Text] [Related]  

  • 45. [Lipoatrophic diabetes with acanthosis nigricans. Prolonged blood glucose normalization by continuous infusion of insulin].
    Leblanc H; Jadaud JM; Dejax C; Saltiel H; Passa P
    Presse Med; 1984 Apr; 13(16):987-9. PubMed ID: 6232527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Congenital insulin-receptor disorder].
    Kazudani H; Yochimasa Y; Kakei T; Ozaki A
    Nihon Naibunpi Gakkai Zasshi; 1991; 67 Suppl 1():156-61. PubMed ID: 2044826
    [No Abstract]   [Full Text] [Related]  

  • 47. Acanthosis Nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children.
    Copeland K; Pankratz K; Cathey V; Immohotichey P; Maddox J; Felton B; McIntosh R; Parker D; Burgin C; Blackett P
    J Okla State Med Assoc; 2006 Jan; 99(1):19-24. PubMed ID: 16499154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin receptor antibodies and insulin resistance.
    Magsino CH; Spencer J
    South Med J; 1999 Jul; 92(7):717-9. PubMed ID: 10414483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial insulin resistance and acanthosis nigricans.
    Praptono R; Sunartini ; Djunduah ; Sadjimin T
    Paediatr Indones; 1990; 30(7-8):213-21. PubMed ID: 2075024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polypeptide hormones: pathology and clinical aspects.
    Van Obberghen E
    Acta Histochem Suppl; 1984; 29():51-5. PubMed ID: 6425926
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
    Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
    J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanisms of insulin resistance in 2 cases of primary insulin receptor defect-associated diseases.
    Tsuji-Hosokawa A; Takasawa K; Nomura R; Miyakawa Y; Numakura C; Hijikata A; Shirai T; Ogawa Y; Kashimada K; Morio T
    Pediatr Diabetes; 2017 Dec; 18(8):917-924. PubMed ID: 28181734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel mutation in insulin receptor gene identified after muscle biopsy in a Niuean woman with severe insulin resistance.
    Murphy R; Smith G; Isaac I; Hutchinson D; Semple RK
    Diabet Med; 2015 Oct; 32(10):e24-8. PubMed ID: 25644898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A mutation (Trp1193-->Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance.
    Iwanishi M; Haruta T; Takata Y; Ishibashi O; Sasaoka T; Egawa K; Imamura T; Naitou K; Itazu T; Kobayashi M
    Diabetologia; 1993 May; 36(5):414-22. PubMed ID: 8390949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) syndrome: spontaneous remission in a 15-year-old girl.
    Esperanza LE; Fenske NA
    J Am Acad Dermatol; 1996 May; 34(5 Pt 2):892-7. PubMed ID: 8621823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Receptors, antireceptor antibodies and mechanisms of insulin resistance.
    Flier JS; Kahn CR; Roth J
    N Engl J Med; 1979 Feb; 300(8):413-9. PubMed ID: 366414
    [No Abstract]   [Full Text] [Related]  

  • 57. The involvement of insulin receptor genotypes in pre- and co-obese acanthosis Nigricans children and adolescent.
    Wang CH; Lin WD; Bau DT; Chou IC; Tsai CH; Tsai FJ
    J Pediatr Endocrinol Metab; 2010 Jul; 23(7):653-60. PubMed ID: 20857837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperandrogenism: new insights into etiology, diagnosis, and therapy.
    Barbieri RL
    Curr Opin Obstet Gynecol; 1992 Jun; 4(3):372-9. PubMed ID: 1623148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exogenous insulin-derived acanthosis nigricans: could it be a cause of increased insulin requirement?
    Dhingra M; Garg G; Gupta M; Khurana U; Thami GP
    Dermatol Online J; 2013 Jan; 19(1):9. PubMed ID: 23374951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.
    Arioglu E; Andewelt A; Diabo C; Bell M; Taylor SI; Gorden P
    Medicine (Baltimore); 2002 Mar; 81(2):87-100. PubMed ID: 11889410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.